Corcept Therapeutics | CORT - 净收入



金融业
股票价格
USD
资产
USD 814.88M
现金及等价物
USD 108.74M
销售成本
USD 2.55M
流动资产
USD 426.03M
流动负债
USD 149.19M
债务
USD 6.11M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD -0.3
股本和储备
USD 637.99M
销售毛利
USD 199.58M
债务利息支出
USD 814.88M
利息收入
USD 5.42M
市值
USD 4.9B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 9.91M
销售收入
USD 164.9M
销售和管理费用
USD 114.75M
股票
USD 12.89M
贸易债权人
USD 33.31M
应收帐款人
USD 59.79M


净收入 更改 日
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Ardelyx USD -407K 562K 2025-12
Assertio Holdings USD -2.92M 753K 2024-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
J&J USD 5.24B 119M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
TG Therapeutics USD 23.04M 367.86M 2025-12